Finance

Lists
KBLB:OTCMKTS
Kraig Biocraft Laboratories Inc
$0.082
+0.79%
(+0.00064) 1D
Sep 11, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KBLB...
Open
$0.08
High
$0.08
Low
$0.08
Mkt. cap
91.06M
Avg. vol.
602.63K
Volume
266.72K
52-wk high
$0.16
52-wk low
$0.07
EPS
-$0.00
Beta
1.56
Shares outstanding
1.12B
No. of employees
41
Open
$0.08
High
$0.08
Low
$0.08
Mkt. cap
91.06M
Avg. vol.
602.63K
Volume
266.72K
52-wk high
$0.16
52-wk low
$0.07
EPS
-$0.00
Beta
1.56
Shares outstanding
1.12B
No. of employees
41
Profile
Kraig Biocraft Laboratories, Inc. is an American biotechnology company headquartered in Ann Arbor, Michigan. It develops and manufactures recombinant spider silks and other high-performance polymers using spider silk gene sequences. Their most notable fiber is dragon silk which has been demonstrated to be tougher than many fibers used in bullet proof vests. Wikipedia
About Kraig Biocraft Laboratories Inc
CEO-
Employees41
Founded2006
HeadquartersAnn Arbor, Michigan, United States
SectorCommodity chemical
Websitekraiglabs.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.24K
68.75K
66.70K
64.37K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.42M
653.92K
758.80K
639.06K
Operating expense
1.43M
722.67K
825.50K
703.43K
Total operating expenses
1.43M
722.67K
825.50K
703.43K
Operating income
-1.43M
-722.67K
-825.50K
-703.43K
Other non operating income
-
-
-
-
EBT including unusual items
-1.51M
-787.62K
-942.72K
-909.54K
EBT excluding unusual items
-1.58M
-860.85K
-963.13K
-835.52K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.51M
-787.62K
-942.72K
-909.54K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.12K
5.94K
10.80K
19.31K
Interest expense
-144.26K
-144.12K
-148.43K
-151.40K
Net interest expenses
-143.14K
-138.18K
-137.63K
-132.09K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.43M
-715.07K
-819.28K
-696.33K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps